Overview Dividends

(ARQQ) Arqit Quantum - Ratings and Ratios

Exchange: NASDAQ • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: KYG0567U1013

QuantumCloud, Encryption, Satellite, Terrestrial, Cybersecurity

Application Software
Market Cap in USD: 340m
IPO / Inception: 2021-09-07
Return 12m vs S&P 500: -38.8%

Dividends

Currently no dividends paid
Risk via 5d forecast
Volatility 151%
Value at Risk 5%th 209%
Relative Tail Risk -15.62%
Reward TTM
Sharpe Ratio 0.40
Alpha -65.06
CAGR/Max DD -0.28
Character TTM
Hurst Exponent 0.434
Beta 2.248
Beta Downside 1.843
Drawdowns 3y
Max DD 95.03%
Mean DD 70.35%
Median DD 74.04%

Description: ARQQ Arqit Quantum December 27, 2025

Arqit Quantum Inc. (NASDAQ: ARQQ) delivers quantum-enhanced cybersecurity solutions from its London base, operating both satellite-based and terrestrial networks. Its flagship offering, QuantumCloud, is a Platform-as-Service that generates “unbreakable” encryption keys using quantum key distribution (QKD), and the firm also sells maintenance, support, and professional services around this technology.

Key industry signals that could affect ARQQ’s outlook include: (1) the global quantum-safe encryption market, projected by IDC to grow at a CAGR of roughly 30 % through 2028, driven by rising regulatory pressure on data protection; (2) the UK government’s £1 billion “Quantum Technologies” investment programme, of which a portion is earmarked for secure communications and may fund pilot deployments; and (3) ARQQ’s recent Q2 2024 financial disclosure showing a 45 % YoY increase in contracted revenue, albeit with a cash burn rate of $12 M per quarter, indicating a need for additional capital to scale.

For a deeper dive into ARQQ’s valuation metrics, you might explore ValueRay’s analyst toolkit.

Piotroski VR‑10 (Strict, 0-10) 0.5

Net Income (-89.9m TTM) > 0 and > 6% of Revenue (6% = 55.4k TTM)
FCFTA -1.55 (>2.0%) and ΔFCFTA 11.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 2719 % (prev 1645 %; Δ 1074 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -1.47 (>3.0%) and CFO -63.0m > Net Income -89.9m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 2.69 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (15.3m) change vs 12m ago NaN% (target <= -2.0% for YES)
Gross Margin -138.5% (prev -175.5%; Δ 36.95pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 2.66% (prev 2.62%; Δ 0.04pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -226.6 (EBITDA TTM -57.1m / Interest Expense TTM 271.0k) >= 6 (WARN >= 3)

Altman Z'' -48.51

(A) 0.59 = (Total Current Assets 40.0m - Total Current Liabilities 14.9m) / Total Assets 42.9m
(B) -8.72 = Retained Earnings (Balance) -373.8m / Total Assets 42.9m
warn (B) unusual magnitude: -8.72 — check mapping/units
(C) -1.77 = EBIT TTM -61.4m / Avg Total Assets 34.8m
(D) -11.48 = Book Value of Equity -179.2m / Total Liabilities 15.6m
Total Rating: -48.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 44.32

1. Piotroski 0.50pt
2. FCF Yield -21.86%
3. FCF Margin data missing
4. Debt/Equity 0.03
5. Debt/Ebitda 0.64
7. RoE -506.5%
8. Rev. Trend 33.74%
9. EPS Trend -18.12%

What is the price of ARQQ shares?

As of January 06, 2026, the stock is trading at USD 27.88 with a total of 637,080 shares traded.
Over the past week, the price has changed by +28.36%, over one month by -8.38%, over three months by -48.24% and over the past year by -28.51%.

Is ARQQ a buy, sell or hold?

Arqit Quantum has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ARQQ.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ARQQ price?

Issuer Target Up/Down from current
Wallstreet Target Price 60 115.2%
Analysts Target Price 60 115.2%
ValueRay Target Price 23 -17.6%

ARQQ Fundamental Data Overview December 31, 2025

Market Cap USD = 340.0m (340.0m USD * 1.0 USD.USD)
P/E Forward = 18.7266
P/S = 641.4309
P/B = 13.1083
Beta = 2.383
Revenue TTM = 924.0k USD
EBIT TTM = -61.4m USD
EBITDA TTM = -57.1m USD
Long Term Debt = 719.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 530.0k USD (from shortTermDebt, last quarter)
Debt = 719.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -36.3m USD (from netDebt column, last quarter)
Enterprise Value = 303.7m USD (340.0m + Debt 719.0k - CCE 37.0m)
Interest Coverage Ratio = -226.6 (Ebit TTM -61.4m / Interest Expense TTM 271.0k)
FCF Yield = -21.86% (FCF TTM -66.4m / Enterprise Value 303.7m)
FCF Margin = -7183 % (FCF TTM -66.4m / Revenue TTM 924.0k)
Net Margin = -9732 % (Net Income TTM -89.9m / Revenue TTM 924.0k)
Gross Margin = -138.5% ((Revenue TTM 924.0k - Cost of Revenue TTM 2.20m) / Revenue TTM)
Gross Margin QoQ = 30.89% (prev 100.0%)
Tobins Q-Ratio = 7.09 (Enterprise Value 303.7m / Total Assets 42.9m)
Interest Expense / Debt = 3.06% (Interest Expense 22.0k / Debt 719.0k)
Taxrate = 10.74% (-2.19m / -20.4m)
NOPAT = -54.8m (EBIT -61.4m * (1 - 10.74%)) [loss with tax shield]
Current Ratio = 2.69 (Total Current Assets 40.0m / Total Current Liabilities 14.9m)
Debt / Equity = 0.03 (Debt 719.0k / totalStockholderEquity, last quarter 27.2m)
Debt / EBITDA = 0.64 (negative EBITDA) (Net Debt -36.3m / EBITDA -57.1m)
Debt / FCF = 0.55 (negative FCF - burning cash) (Net Debt -36.3m / FCF TTM -66.4m)
Total Stockholder Equity = 17.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -209.9% (out of range, set to none)
RoE = -506.5% (Net Income TTM -89.9m / Total Stockholder Equity 17.8m)
RoCE = -332.5% (out of range, set to none) (EBIT -61.4m / Capital Employed (Equity 17.8m + L.T.Debt 719.0k))
RoIC = -298.9% (out of range, set to none) (NOPAT -54.8m / Invested Capital 18.3m)
WACC = 14.28% (E(340.0m)/V(340.7m) * Re(14.30%) + D(719.0k)/V(340.7m) * Rd(3.06%) * (1-Tc(0.11)))
Discount Rate = 14.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 53.50%
Fair Price DCF = unknown (Cash Flow -66.4m)
EPS Correlation: -18.12 | EPS CAGR: -34.59% | SUE: -1.06 | # QB: 0
Revenue Correlation: 33.74 | Revenue CAGR: 238.1% | SUE: -0.00 | # QB: 0
EPS current Year (2026-09-30): EPS=-1.52 | Chg30d=+0.130 | Revisions Net=+1 | Growth EPS=+29.8% | Growth Revenue=+368.3%
EPS next Year (2027-09-30): EPS=-1.06 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+30.3% | Growth Revenue=+214.2%

Additional Sources for ARQQ Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle